AvidBiotics Corporation is a biotechnology company developing non-antibody proteins as targeted therapeutics, The firm has two proprietary product platforms. One: a new class of tailorable, targeted bactericidal agents for use in the treatment or prevention of specific bacterial infections or contaminations. Two: a technology platform specifically flags virus-infected or cancerous cells for enhanced destruction by the Natural Killer and T-cells of the potent innate immunity system. AvidBiotics focuses on human therapeutic applications of its technologies, both on its own and in partnership with governmental agencies and research institutions, while taking advantage of further near-term collaborative opportunities offered by specific applications of its products and technology platforms in areas such as food safety, biodefense and animal husbandry. Headed up by a highly experienced biotech industry players, the firm has important collaborations with two major corporations.
